Commentary & Reflection
The book opens with a historical reconstruction of DMT — from its obscure synthesis and Szára’s early work to Strassman’s own rediscovery in the 1990s. This part is exceptional: it situates DMT within the lineage of modern psychedelics and captures the institutional barriers surrounding human research. His account of grant writing, ethics board reviews, and DEA negotiations feels surprisingly contemporary for anyone working in academia, the same bureaucratic friction, just amplified by the stigma of the time.
The section on melatonin and the pineal gland reflects Strassman’s 1980s attempt to bridge biochemistry and spirituality. He speculates that DMT could play a role in birth, death, and near-death experiences, tying it to the pineal as a “spirit molecule” center. While imaginative and influential, this hypothesis hasn’t aged well, subsequent research (including Borjigin’s rodent studies) supports DMT biosynthesis in the brain but not its causal role in consciousness transitions. It reads today as a mix of pioneering vision and 1990s metaphysical optimism.
The later chapters describing how he conceived and launched the human DMT study are the real core of the book. He portrays the process with honesty, long stretches of doubt, institutional rejection, and eventual approval through persistence. For scientists, it’s a portrait of curiosity under taboo: how to pursue truth when the field itself is stigmatized.
In retrospect, The Spirit Molecule sits at a crossroads — between scientific caution and spiritual speculation, post-war restraint and modern renaissance. It reignited DMT’s public and academic presence, even if parts of its theory now seem dated. Strassman’s newer book, My Altered States (2024), reframes his journey entirely — more introspective, personal, and critical of his own earlier conclusions — offering a kind of sequel from a mature perspective that the original never aimed for.
The Four Aims of Strassman’s Initial DMT Study Proposal (1987–1989)
- Recruit “well-functioning, experienced hallucinogen users” as volunteers
- Chosen to ensure participants could handle powerful effects, describe them accurately, and avoid panic.
- Also minimized ethical and legal risks: participants had prior exposure and were less likely to claim harm or “first-time” influence.
- Develop a reliable method to measure DMT in human blood
- Adapt existing NIMH assays to determine plasma levels and correlate them with intensity and timing of effects.
- This would form the pharmacokinetic backbone of the project.
- Create a new rating scale for DMT’s psychological effects
- Existing psychiatric scales presumed “psychosis.”
- Strassman wanted one built from interviews with actual psychedelic users — language reflecting insight and visionary experience rather than pathology.
- Characterize psychological and physical responses across several doses of DMT
- A systematic dose-response design: placebo, low, medium, and high doses.
- Record both subjective and objective physiological data (heart rate, blood pressure, pupil dilation, temperature, hormone levels). → he needed to frame the proposal in a way that it remain strictly biomedical, avoiding psychotherapy or mysticism.